Axsome Therapeutics, Inc.
NASDAQ: AXSM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Herriot Tabuteau
- Employees
- 712
- Headquarters
- New York City, United States
- IPO year
- 2015
- Market cap
- $12.9B
- Website
- https://www.axsome.com
Loading AXSM…
Loading profile data…Frequently asked questions about AXSM
What does Axsome Therapeutics, Inc. (AXSM) do?
Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for a range of central nervous system (CNS) disorders within the United States. Its robust product pipeline features several promising candidates, including: AXS-05, an investigational therapy currently being developed for major...
Where does AXSM trade?
Axsome Therapeutics, Inc. (AXSM) trades on the NASDAQ Global Market.
What sector is AXSM in?
Axsome Therapeutics, Inc. (AXSM) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Axsome Therapeutics, Inc.?
Herriot Tabuteau is the chief executive officer of Axsome Therapeutics, Inc. (AXSM).
Where is Axsome Therapeutics, Inc. headquartered?
Axsome Therapeutics, Inc. is headquartered in United States.
Does AXSM pay a dividend?
Axsome Therapeutics, Inc. (AXSM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AXSM go public?
Axsome Therapeutics, Inc. (AXSM) completed its initial public offering in 2015.